NDC product
QUINIDINE SULFATE
NDC 42806-512 · EPIC PHARMA, LLC
Key facts
| Product NDC | 42806-512 |
|---|---|
| Proprietary name | QUINIDINE SULFATE |
| Nonproprietary name | quinidine sulfate tablet |
| Substances | QUINIDINE SULFATE |
| Dosage form | TABLET |
| Route | ORAL |
| Labeler | EPIC PHARMA, LLC |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | ANDA |
| Application number | ANDA088072 |
| Pharmacologic classes | Antiarrhythmic [EPC], Cytochrome P450 2D6 Inhibitor [EPC], Cytochrome P450 2D6 Inhibitors [MoA] |
| Marketing start | Dec 15, 2021 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: